Techno Trends
TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.
Daiichi Sankyo Introduces First-of-its-kind ENHERTU® for Metastatic Breast Cancer
Daiichi Sankyo has introduced ENHERTU®, a groundbreaking treatment option for certain patients with HER2 low or HER2 ultralow metastatic breast cancer. ENHERTU is a leading antibody-drug conjugate (ADC) in oncology portfolio, designed using proprietary DXd ADC technology.
Duke-NUS Medical School Discovered Breakthrough Treatment for Neurodevelopmental Disorders
Researchers at Duke-NUS Medical School and the Mechanobiology Institute (MBI) at the National University of Singapore (NUS) have uncovered a novel pathway that can awaken dormant neural stem cells, paving the way for potential new therapies for neurodevelopmental disorders such
Novartis Discovered First-of-its-Kind Fabhalta (iptacopan) Immunoglobulin A Nephropathy
Novartis has introduced Fabhalta (iptacopan), a first-of-its-kind treatment designed to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression. Fabhalta specifically targets the alternative complement pathway
Attralus Introduces First 124I-evuzamitide (AT-01) for Cardiac Amyloidosis
Attralus has introduced 124I-evuzamitide (AT-01), the first pan-amyloid diagnostic PET imaging candidate designed for cardiac amyloidosis. Recognised for its potential as a groundbreaking diagnostic tool, 124I-evuzamitide
Adaptimmune Therapeutics Introduces Breakthrough TECELRA® Cell Therapy for Solid Tumor
Adaptimmune Therapeutics has unveiled TECELRA® (afamitresgene autoleucel), a groundbreaking treatment for adults with unresectable or metastatic synovial sarcoma who have previously undergone chemotherapy. TECELRA® (afamitresgene autoleucel) is a genetically modified autologous T cell immunotherapy
Indiana University Unveils Ground Breaking New Gene Therapy for Duchenne Muscular Systrophy
Indiana University has introduced a groundbreaking gene therapy technique that restores the full-length dystrophin protein, potentially leading to new treatments for Duchenne muscular dystrophy
AusperBio Therapeutics Introduces Novel AHB-137 for Chronic Hepatitis B Treatment
AusperBio Therapeutics has introduced AHB-137, a groundbreaking treatment for chronic hepatitis B (CHB). With approximately 296 million people globally affected by chronic HBV and limited treatment options for a cure, the disease
Sanofi Unveils Ground breaking Dupixent Therapy for Chronic Obstructive Pulmonary Disease
Sanofi has introduced Dupixent, a groundbreaking addition to maintenance therapy for adults suffering from uncontrolled chronic obstructive pulmonary disease characterised by elevated blood
Eli Lilly Introduced First-of-its-kind Kisunla™ for Alzheimer's Disease
Eli Lilly has launched Kisunla™, a groundbreaking therapy for adults with early symptomatic Alzheimer's disease, encompassing those with mild cognitive impairment
Ligand Pharmaceuticals Develops Novel Ohtuvayre™ for the Treatment of Chronic Obstructive Pulmonary Disease
Ligand Pharmaceuticals has developed Ohtuvayre™, the first inhaled treatment with a novel mechanism for chronic obstructive pulmonary disease in over 20 years.
